GW PHARMACEUTICALS PLC's ticker is GWPH and the CUSIP is 36197T103. A total of 276 filers reported holding GW PHARMACEUTICALS PLC in Q3 2018. The put-call ratio across all filers is 1.31 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2021 | $60,900,000 | -80.9% | 280,774 | -89.8% | 0.01% | -82.0% |
| Q4 2020 | $318,187,000 | +18.7% | 2,757,013 | +0.1% | 0.06% | +3.4% |
| Q3 2020 | $268,165,000 | +17.2% | 2,754,644 | +47.7% | 0.06% | +7.3% |
| Q2 2020 | $228,894,000 | +129.3% | 1,865,171 | +63.6% | 0.06% | +89.7% |
| Q1 2020 | $99,827,000 | -13.6% | 1,139,964 | +3.2% | 0.03% | +11.5% |
| Q4 2019 | $115,497,000 | +6.2% | 1,104,605 | +16.9% | 0.03% | 0.0% |
| Q3 2019 | $108,717,000 | -76.7% | 945,114 | -65.2% | 0.03% | -76.4% |
| Q2 2019 | $467,552,000 | +2.3% | 2,712,176 | +0.0% | 0.11% | -0.9% |
| Q1 2019 | $457,090,000 | +73.1% | 2,711,574 | +0.0% | 0.11% | +54.2% |
| Q4 2018 | $264,080,000 | -39.3% | 2,711,572 | +7.7% | 0.07% | -32.1% |
| Q3 2018 | $434,802,000 | +42.9% | 2,517,090 | +15.4% | 0.11% | +63.1% |
| Q2 2018 | $304,372,000 | +23.8% | 2,181,250 | 0.0% | 0.06% | +18.2% |
| Q1 2018 | $245,761,000 | +29.7% | 2,181,250 | +51.9% | 0.06% | +34.1% |
| Q4 2017 | $189,550,000 | +176.4% | 1,435,879 | +112.5% | 0.04% | +156.2% |
| Q3 2017 | $68,587,000 | +1.2% | 675,800 | 0.0% | 0.02% | 0.0% |
| Q2 2017 | $67,749,000 | -11.9% | 675,800 | +6.3% | 0.02% | -11.1% |
| Q1 2017 | $76,894,000 | +8.2% | 635,800 | 0.0% | 0.02% | 0.0% |
| Q4 2016 | $71,051,000 | -29.6% | 635,800 | -16.4% | 0.02% | -30.8% |
| Q3 2016 | $100,981,000 | +152.3% | 760,800 | +74.1% | 0.03% | +136.4% |
| Q2 2016 | $40,025,000 | +26.9% | 437,100 | 0.0% | 0.01% | +22.2% |
| Q1 2016 | $31,537,000 | +3.9% | 437,100 | 0.0% | 0.01% | +12.5% |
| Q4 2015 | $30,352,000 | -24.0% | 437,100 | 0.0% | 0.01% | -33.3% |
| Q3 2015 | $39,938,000 | -25.6% | 437,100 | 0.0% | 0.01% | -20.0% |
| Q2 2015 | $53,693,000 | +68.3% | 437,100 | +24.9% | 0.02% | +66.7% |
| Q1 2015 | $31,905,000 | +124.5% | 350,100 | +66.7% | 0.01% | +125.0% |
| Q4 2014 | $14,213,000 | – | 210,000 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| GREAT POINT PARTNERS LLC | 450,000 | $55,224,000 | 4.41% |
| Parkman Healthcare Partners LLC | 119,778 | $14,699,000 | 4.14% |
| Sio Capital Management, LLC | 94,984 | $11,656,000 | 3.40% |
| Tamarack Advisers, LP | 90,000 | $11,045,000 | 3.08% |
| Copernicus Capital Management, LLC | 22,000 | $2,700,000 | 2.96% |
| Integral Health Asset Management, LLC | 75,000 | $9,204,000 | 2.76% |
| ETF MANAGERS GROUP, LLC | 480,145 | $58,923,000 | 2.09% |
| AdvisorShares Investments LLC | 29,758 | $3,652,000 | 1.55% |
| Redwood Investments, LLC | 130,444 | $16,008,000 | 1.42% |
| CLOUGH CAPITAL PARTNERS L P | 100,746 | $12,364,000 | 1.21% |